THE SOCIAL FINANCIAL LOAD OF OPPORTUNISTIC SCREENING OF BREAST CANCER

封面

如何引用文章

全文:

详细

The study was carried out concerning complex evaluation of financial load of opportunistic screening of breast cancer. The data of established cases of breast cancer and stages of disease are taken from collections "The state of oncologic care in Russia" 2014, 2015 and 2016. The financial expenses for implementation of analog mammography, sonography and physician's examination are taken from "The territorial tariff agreement 2014". The evaluation of X-ray finds was implemented using categories BI-RADS (Breast Imaging Reporting and Data System) proposed by the American College of Radiology. During 2014, in the Primorskiy Krai 40,825 of diagnostic and 50,824 cases of preventive mammography were implemented. In 2015 43,196 diagnostic and 58,567 preventive examinations and in 2016 47,359 diagnostic and 53 973 preventive examinations were implemented correspondingly. According the Foundation of mandatory medical insurance, the price of analog mammography made up to 292 rubles. The social financial load of diagnostic of a single case of breast cancer at stage T1 made up to 96,367 rubles in 2014, 90,966 rubles in 2015 and 73,303 rubles in 2016 correspondingly. The analysis of detection of breast cancer at early stage T1 and financial costs of early diagnostic demonstrated a distinct trend of decreasing of financial load at diagnostic of a single case of breast cancer of T1 during 2014-2016 at the expense of amelioration of quality of description of picture and training of radiologists. The model was proposed to form groups of higher risk with subsequent detailed examination and implementation of opportunistic screening in the group of common level of risk of development of breast cancer as a most perspective and less unprofitable one.

作者简介

V. Apanasevich

The Pacific State Medical University; The Primorskiy Regional Oncologic Dispensary

编辑信件的主要联系方式.
Email: oncolog222@gmail.com
俄罗斯联邦

P. Kiku

The Far East Federal University, the School of Biomedicine

Email: noemail@neicon.ru
俄罗斯联邦

A. Faizinger

The Primorskiy Krai hospital №1

Email: noemail@neicon.ru
俄罗斯联邦

O. Zagrudinova

The Primorskiy Regional Oncologic Dispensary

Email: noemail@neicon.ru
俄罗斯联邦

A. Sedykh

The Primorskiy Regional Oncologic Dispensary

Email: noemail@neicon.ru
俄罗斯联邦

S. Yudin

The Pacific State Medical University

Email: noemail@neicon.ru
俄罗斯联邦

V. Moreva

The Far East Federal University, the School of Biomedicine

Email: noemail@neicon.ru
俄罗斯联邦

A. Sukhova

The F.F. Erisman Federal Research Center of Hygiene

Email: noemail@neicon.ru
俄罗斯联邦

参考

  1. Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Состояние онкологической помощи населению России в 2016 году. М.; 2017.
  2. Mariotto A., Etzioni R., Hurlbert M., Penberthy L., Mayer M. Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States. Cancer Epidemiol. Biomarkers Prev. 2017; 26(6): 809-15.
  3. Health Quality Ontario. Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: A Health Technology Assessment. Ont. Health. Technol. Assess Ser. 2016; 16(15): 1-71.
  4. Wadasadawala T., Kannan S., Gudi S., Rishi A., Budrukkar A., Parmar V., et al. Predicting loco-regional recurrence risk in T1,T2 breast cancer with 1-3 positive axillary nodes postmastectomy: Development of a predictive nomogram. Indian J. Cancer. 2017; 54(1): 352-7.
  5. Gray E., Donten A., Karssemeijer N., van Gils C., Evans D.G., Astley S., et al. Value Health. Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis. Value Health. 2017; 20(8): 1100-9.
  6. Комарова Л.Е. Скрининговая маммография рака молочной железы. За и против? Сибирский онкологический журнал. 2008; (Прил. 2): 2-14.
  7. Колядина И.В., Поддубная И.В., Комов Д.В. Скрининг рака молочной железы: мировой опыт и перспективы. Российский онкологический журнал. 2015; 20(1): 42-6.
  8. Szynglarewicz B., Matkowski R. Ductal carcinomas in situ and invasive cancers detected on screening mammography: Cost-effectiveness of initial and subsequent rounds of population-based program 2007-2014. Adv. Clin. Exp. Med. 2017; 26(2): 259-62.
  9. Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Состояние онкологической помощи населению России в 2014 году. М.; 2015.
  10. Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Состояние онкологической помощи населению России в 2015 году. М.; 2016.
  11. Территориальное тарифное соглашение на 2014 год. Available at: http://www.omspk.ru/upload/iblock/a75/dopcogl%20N17_tts_2014_ot_13.02.15.doc
  12. Мордвинов Ю.П., Апанасевич В.И., Болтаев Ю.Ю. Возможности предоперационной диагностики склерозирующего аденоза молочной железы. Тихоокеанский медицинский журнал. 2017; (1): 58-61.
  13. Приказ ДЗАПК №129-0 «О проведении скрининговых мероприятий по раннему выявлению онкологических заболеваний» от 02.03.2015г. Available at: http://docs.cntd.ru/document/428540802
  14. Hanley J.A., Hannigan A., O'Brien K.M. Mortality reductions due to mammography screening: Contemporary population-based data. PLoS One. 2017; 12(12): e0188947.
  15. Kuhl C., Weigel S., Schrading S., Arand B., Bieling H., Konig R, et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J. Clin. Oncol. 2010; 28(9): 1450-7.
  16. Berg W.A., Zhang Z., Lehrer D., Jong R.A., Pisano E.D., Barr R.G. et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012; 307(13): 1394-404.
  17. Wanders J.O., Holland K., Veldhuis W.B., Mann R.M., Pijnappel R.M., Peeters P.H. et al. Volumetric breast density affects performance of digital screening mammography. Breast Cancer Res. Treat. 2017; 162(1): 95-103.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Apanasevich V.I., Kiku P.F., Faizinger A.G., Zagrudinova O.M., Sedykh A.A., Yudin S.V., Moreva V.G., Sukhova A.V., 2020

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ:  ПИ № ФС77-50668 от 13.07.2012 г.